行情

KMDA

KMDA

Kamada
NASDAQ

实时行情|Nasdaq Last Sale

5.20
+0.01
+0.19%
已收盘, 16:00 10/22 EDT
开盘
5.17
昨收
5.19
最高
5.20
最低
5.17
成交量
1.03万
成交额
--
52周最高
6.70
52周最低
4.633
市值
2.10亿
市盈率(TTM)
8.16
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

KMDA 新闻

  • Kamada to Present Corporate Overview at the 2019 Cantor Global Healthcare Conference
  • GlobeNewswire.09/24 12:00
  • 美国国务卿蓬佩奥谴责伊朗袭击沙特油田
  • 央视.09/14 22:10
  • 在美国腐败调查的阴影下 UAW和通用汽车接近合同期限
  • 新浪美股.09/14 21:54
  • 马斯克强调物流速度:亚马逊要像特斯拉一样早破产了
  • 新浪美股.09/14 20:38

更多

所属板块

制药
+0.64%
制药与医学研究
+0.60%

热门股票

名称
价格
涨跌幅

KMDA 简况

Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology. It offers bio-therapeutics for human use, such as specialty proteins, specific immunoglobulins, and other prescription medicines. The Company’s product line includes intravenous AAT for chronic replacement therapy in individuals with congenital alpha-1 antitrypsin deficiency; KamRAB for prophylaxis of rabies infection; KamRho-D IM for prophylaxis of Rh hemolytic disease of the newborn; KamRho-D IV for treatment of immune thrombocytopenic purpura; and IVIG, a replacement therapy in primary and secondary immune therapy. Its product line also comprises Protosol to reduce blood loss in patients undergoing cardiac surgery; Heparin sodium injection for coagulation inhibition and prophylaxis of thromboembolic diseases and Heparin Lock Flush to maintain potency of intravenous injection device among other.
展开

Webull提供Kamada Ltd.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。